Terms: = Brain cancer AND PSA
127 results:
1. brain metastasis in a patient with BRCA2-mutated treatment-related neuroendocrine prostate carcinoma and long-term response to radiotherapy and Olaparib: A case report and literature review.
Uehara R; Obinata D; Hashimoto S; Nakahara K; Uchida H; Yoshizawa T; Mochida J; Yamaguchi K; Sakaguchi M; Ozawa Y; Mori F; Miura K; Ishige T; Masuda S; Nakayama T; Takahashi S
Medicine (Baltimore); 2024 Mar; 103(9):e37371. PubMed ID: 38428891
[TBL] [Abstract] [Full Text] [Related]
2. Treatment modalities and survival outcomes in prostate cancer parenchymal brain metastasis.
Mahmoud AM; Childs DS; Ahmed ME; Tuba Kendi A; Johnson GB; Orme JJ; Stish BJ; Phillips RM; Park SS; Davis BJ; Andrews JR; Kwon ED
Prostate; 2024 Feb; 84(3):237-244. PubMed ID: 37899635
[TBL] [Abstract] [Full Text] [Related]
3. Primary high-grade urothelial carcinoma of prostate with prostatic hyperplasia: a rare case report and review of the literature.
Liu L; Sun FZ; Zhang PY; Xiao Y; Yue X; Wang DM; Wang Q
Aging Male; 2023 Dec; 26(1):2252102. PubMed ID: 37642413
[TBL] [Abstract] [Full Text] [Related]
4. Clinical Pharmacokinetics and Pharmacodynamics of the Next Generation Androgen Receptor Inhibitor-Darolutamide.
Podgoršek E; Mehra N; van Oort IM; Somford DM; Boerrigter E; van Erp NP
Clin Pharmacokinet; 2023 Aug; 62(8):1049-1061. PubMed ID: 37458966
[TBL] [Abstract] [Full Text] [Related]
5. Cost-effectiveness of sacituzumab govitecan versus chemotherapy in patients with relapsed or refractory metastatic triple-negative breast cancer.
Xie J; Li S; Li Y; Li J
BMC Health Serv Res; 2023 Jun; 23(1):706. PubMed ID: 37386633
[TBL] [Abstract] [Full Text] [Related]
6. Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate cancer.
Hamdy FC; Donovan JL; Lane JA; Metcalfe C; Davis M; Turner EL; Martin RM; Young GJ; Walsh EI; Bryant RJ; Bollina P; Doble A; Doherty A; Gillatt D; Gnanapragasam V; Hughes O; Kockelbergh R; Kynaston H; Paul A; Paez E; Powell P; Rosario DJ; Rowe E; Mason M; Catto JWF; Peters TJ; Oxley J; Williams NJ; Staffurth J; Neal DE;
N Engl J Med; 2023 Apr; 388(17):1547-1558. PubMed ID: 36912538
[TBL] [Abstract] [Full Text] [Related]
7. Towards Developing Novel Prostate cancer Recurrence Suppressors: Acute Toxicity of Pseurotin A, an Orally Active PCSK9 Axis-Targeting Small-Molecule in Swiss Albino Mice.
McGehee OC; Ebrahim HY; Rad AH; Abdelwahed KS; Mudhish EA; King JA; Helal IE; Meyer SA; El Sayed KA
Molecules; 2023 Feb; 28(3):. PubMed ID: 36771126
[TBL] [Abstract] [Full Text] [Related]
8. Construction and validation of web-based nomograms for detecting and prognosticating in prostate adenocarcinoma with bone metastasis.
Dong Q; Wu X; Gan W; Mok TN; Shen J; Zha Z; Chen J
Sci Rep; 2022 Nov; 12(1):18623. PubMed ID: 36329203
[TBL] [Abstract] [Full Text] [Related]
9. Impact of Novel Hormonal Agents (Abiraterone, Enzalutamide) on the Development of Visceral and/or brain Metastases in Patients With Bone-metastatic Castration-resistant Prostate cancer.
Pobel C; Laurent E; Florence AM; Fromont G; Calais G; Narciso B; Linassier C; Cancel M
Clin Genitourin Cancer; 2022 Oct; 20(5):495.e1-495.e9. PubMed ID: 35562276
[TBL] [Abstract] [Full Text] [Related]
10. LncRNA-MALAT1 Regulates cancer Glucose Metabolism in Prostate cancer via MYBL2/mTOR Axis.
Mu X; Shen Z; Lin Y; Xiao J; Xia K; Xu C; Chen B; Shi R; Zhu A; Sun X; Tao T; Song X; Xuan Q
Oxid Med Cell Longev; 2022; 2022():8693259. PubMed ID: 35557985
[TBL] [Abstract] [Full Text] [Related]
11. Identification and Validation of the Prognostic Impact of Metastatic Prostate cancer Phenotypes.
Labe SA; Wang X; Lehrer EJ; Kishan AU; Spratt DE; Lin C; Morgans AK; Ponsky L; Garcia JA; Garrett S; Wang M; Zaorsky NG
Clin Genitourin Cancer; 2022 Aug; 20(4):371-380. PubMed ID: 35383004
[TBL] [Abstract] [Full Text] [Related]
12. Induction of IDO1 and Kynurenine by Serine Proteases Subtilisin, Prostate Specific Antigen, CD26 and HtrA: A New Form of Immunosuppression?
Clanchy FIL; Huang YS; Ogbechi J; Darlington LG; Williams RO; Stone TW
Front Immunol; 2022; 13():832989. PubMed ID: 35371018
[TBL] [Abstract] [Full Text] [Related]
13. Mask-Based versus Frame-Based Gamma Knife ICON Radiosurgery in brain Metastases: A Prospective Randomized Trial.
Régis J; Merly L; Balossier A; Baumstarck K; Hamdi H; Mariani S; Delsanti C; Vincent M; Nigoul JM; Beltaifa Y; Muracciole X
Stereotact Funct Neurosurg; 2022; 100(2):86-94. PubMed ID: 34933308
[TBL] [Abstract] [Full Text] [Related]
14. Prostate cancer Metastasis to the Pituitary Gland Manifesting as Corticosteroid Withdrawal, and the Impact of the Switch from Prednisone to Dexamethasone on Survival Time.
Ataikiru O; Abdelsalam M; Avileli M; Hynes T
Curr Oncol; 2021 Oct; 28(6):4291-4297. PubMed ID: 34898537
[TBL] [Abstract] [Full Text] [Related]
15. Hydrogel-based hybridization chain reaction (HCR) for detection of urinary exosomal miRNAs as a diagnostic tool of prostate cancer.
Kim J; Shim JS; Han BH; Kim HJ; Park J; Cho IJ; Kang SG; Kang JY; Bong KW; Choi N
Biosens Bioelectron; 2021 Nov; 192():113504. PubMed ID: 34298498
[TBL] [Abstract] [Full Text] [Related]
16. TGM4: an immunogenic prostate-restricted antigen.
Lopez-Bujanda ZA; Obradovic A; Nirschl TR; Crowley L; Macedo R; Papachristodoulou A; O'Donnell T; Laserson U; Zarif JC; Reshef R; Yuan T; Soni MK; Antonarakis ES; Haffner MC; Larman HB; Shen MM; Muranski P; Drake CG
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34193566
[TBL] [Abstract] [Full Text] [Related]
17. Solitary brain metastasis after recurrent adenocarcinoma of the prostate.
Rodriguez-Homs M; Wiesen B; Rizeq M; Randau C; Lloyd GL
Can J Urol; 2021 Feb; 28(1):10565-10567. PubMed ID: 33625349
[TBL] [Abstract] [Full Text] [Related]
18. [A Case of Paraneoplastic Opsoclonus and Ataxia Appeared at Progression of Prostate cancer].
Kurihara K; Fukuhara K; Yanamoto S; Tsugawa J; Tsuboi Y
Brain Nerve; 2021 Feb; 73(2):179-182. PubMed ID: 33561832
[TBL] [Abstract] [Full Text] [Related]
19. Polysialylation and disease.
Sato C; Kitajima K
Mol Aspects Med; 2021 Jun; 79():100892. PubMed ID: 32863045
[TBL] [Abstract] [Full Text] [Related]
20. Evaluation of the effects of androgenic Chinese herbal medicines on androgen receptors and tumor growth in experimental prostate cancer models.
Zhang ZB; Ip SP; Cho WC; Hu Z; Huang YF; Luo DD; Xian YF; Lin ZX
J Ethnopharmacol; 2020 Oct; 260():113058. PubMed ID: 32525068
[TBL] [Abstract] [Full Text] [Related]
[Next]
